Bi-Cure Remedies
PCD Pharma Franchise for Cardiac and Cholesterol Products Range
Description
A preferred agent among the ACE inhibitor class
- Decreases vasopressor activity, aldosterone secretion and bradykinin degradation
Effectively reduces cardiovascular high risk hypertensive patients
- Ramipril is generally well tolerated and effective in the treatment of patients aged> or =55 years at high risk for the development of cardiovascular (CV) events, in whom the risk of myocardial infarction (MI), Stroke and CV death can be significantly reduced.
Indicated in:
- Primary hypertension
- Hypertension with diabetes mellitus
- Hypertension with renal insufficiency
- Hypertension with congestive heart failure